Oura, the maker of the health and wellness tracking smart ring, has confidentially filed for an IPO with the SEC.
Yotta Data Services is considering an initial public offering in Mumbai that could raise as much as US$900 million, according to sources familiar with the matter, as reported by Bloomberg. The company ...
Anthropic just made Elon Musk's SpaceX a key supplier to its AI ambitions, and the timing is hard to miss. The Claude maker said Wednesday it had signed a deal to tap all of the compute capacity at ...
Blackstone’s quest to launch a public data center acquisition business took another big step this week. Blackstone Digital Infrastructure Trust filed for an initial public offering with the Securities ...
Blackstone Digital Infrastructure Trust filed for an initial public offering on Monday, projecting to issue 87,500,000 shares of common stock at $20 per share. To sweeten the offering, the trust will ...
Chip startup Cerebras Systems will offer 28 million shares in its planned initial public offering at a price of $115 to $125 a share. The IPO would raise $3.5 billion at the upper end of the pricing ...
May 4 (Reuters) - A newly minted Blackstone (BX.N), opens new tab investment vehicle is aiming to raise slightly over $1.7 billion in an initial public offering in the United States to capitalize on ...
The upcoming SpaceX IPO should make history. There are already ways to invest in SpaceX today. But these methods are largely buying shares that have already been issued. The IPO, meanwhile, will issue ...
Amid a flood of Big Tech earnings, one trend was clear: The ‘picks and shovels’ trade for the artificial intelligence boom is roaring. As hyperscalers like Microsoft MSFT and Meta META plow billions ...
The few drugs available for lung disorders that cause scarring of the organ are pills that circulate throughout the body. Avalyn Pharma is aiming for a better effect with inhalable medicines, and the ...
Avalyn Pharma has overshot its expectations with a $300 million IPO that the biotech will use to fund late-stage studies of its inhaled versions of approved respiratory drugs. The company is offering ...
ChatGPT is still growing its user base, but that growth is slowing down, especially compared to rival Claude. ChatGPT is still growing its user base, but that growth is slowing down, especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results